Source: The Very Good Food Company.
  • The Very Good Food Company (VERY) has secured a US$6.5M institutional private placement
  • The company will use net proceeds for general working capital purposes
  • The offering is expected to close on or about June 2, 2022
  • The Very Good Food Company produces nutritious plant-based meat and cheese products
  • The Very Good Food Company (VERY) is down by 3.13 per cent trading at $0.31 per share

The Very Good Food Company (VERY) has secured a US$6.5M institutional private placement.

The news follows major retail expansion in the Canadian market.

It will sell 32,500,000 units priced at US$0.20, each comprised of one common share and one purchase warrant.

Each warrant entitles the holder to acquire one share exercisable at US$0.2582 for up to five years from issuance.

The company will use net proceeds for general working capital purposes.

H.C. Wainwright & Co. is acting as the exclusive placement agent.

The offering is expected to close on or about June 2, 2022.

No securities were offered or sold to Canadian residents.

The Very Good Food Company produces nutritious plant-based meat and cheese products.

The Very Good Food Company (VERY) is down by 3.13 per cent trading at $0.31 per share at 10:17 am EST.

More From The Market Online

“Paw Patrol” owners see a 52-week share price high

Spin Master (TSX:TOY) reported 8.9 per cent revenue growth to US$436.4 million and returned to profitability.

Uber Eats expands grocery delivery network with new U.S. regional retail partners

Uber (NYSE:UBER) Eats added Busch’s Fresh Food Market, Hays, and Lowe’s Market to its grocery delivery marketplace across the U.S.

Cybersecurity stocks worth watching as digital risks continue to evolve

Cybersecurity threats continue to evolve, while recent disruptions highlighted the importance of resilient digital infrastructure.

A small-cap contender looking to challenge the weight-loss drug giants

Structure Therapeutics (NASDAQ:GPCR) is developing an oral weight-loss pill that could offer an alternative to popular injectable treatments.